Implantation defects are responsible for a significant percentage of pregnancy failure during natural pregnancy and in vitro fertilization procedures, yet very little is known about the molecular interactions between implanting blastocysts and the hormonally primed uterus. Two AbdominalB-like homeobox genes, Hoxa-10 and Hoxa-11, have been implicated in both uterine development and functioning of the adult uterus during implantion. Mice deficient for Hoxa-10 exhibit defects in uterine development and reduced female fertility due to defects in uterine stroma to confer uterine receptivity. During implantion, Hoxa-10 functions in a hormonally regulated pathway and likely converges with another implantation pathway involving prostaglandin E2 and its receptors. In addition, both Hoxa-10 and Hoxa-11 are required for hormonemediated stromal cell proliferation during implantation. Based on previous studies, we hypothesize that during implantation, ovarian hormones directly regulate Hoxa-10 and Hoxa-11 gene expression through binding of steroid hormone receptors to hormone response elements located in the Hoxa-10/Hoxa-11 loci. In turn Hoxa-10 and Hoxa-11 can regulate the expression of cell cycle control molecules to promote hormone-induced cellular proliferation. In addition, we hypothesize that a genetic pathway involving Hox and Wnt genes controls uterine development and exogenous hormones such as DES can affect reproductive tract development by modulating this genetic pathway. This proposal will rigorously test the above hypotheses.
Aim 1 is designed to use transgenic mice to examine the in vivo functional significance of two progesterone response elements identified in our preliminary studies.
In Aim 2, we propose to identify and characterize a DES-responsive element located in the Hoxa-11/Hoxa-10 loci. Finally in Aim 3, we propose to examine the genetic relationship between Hox and Wnt genes during uterine development and test whether DES can repress Wnt-7a expression through Hoxa-10 or Hoxa-11. Our long term goal is to use mouse as a model to study the genetic pathways controlling implantation and uterine development, which would provide us with the necessary knowledge to design better drugs to preserve natural pregnancy or to improve the in vitro fertilization protocol.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD041492-02
Application #
6722917
Study Section
Reproductive Biology Study Section (REB)
Program Officer
Yoshinaga, Koji
Project Start
2003-04-01
Project End
2004-06-30
Budget Start
2004-04-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$9,720
Indirect Cost
Name
Tulane University
Department
Anatomy/Cell Biology
Type
Schools of Arts and Sciences
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Cai, Jing; Lee, Jonghyeob; Kopan, Raphael et al. (2009) Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation. Dev Biol 326:420-30
Yin, Yan; Huang, Wei-Wei; Lin, Congxing et al. (2008) Estrogen suppresses uterine epithelial apoptosis by inducing birc1 expression. Mol Endocrinol 22:113-25
Tan, Yung-Chieh; Shen, Amy Q; Li, Yu et al. (2008) Engineering lipid tubules using nano-sized building blocks: the combinatorial self-assembly of vesicles. Lab Chip 8:339-45
Lin, Congxing; Yin, Yan; Long, Fanxin et al. (2008) Tissue-specific requirements of beta-catenin in external genitalia development. Development 135:2815-25
Yin, Yan; Lin, Congxing; Ma, Liang (2006) MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol. Mol Endocrinol 20:1535-46
Huang, Wei-Wei; Yin, Yan; Bi, Qun et al. (2005) Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol 19:669-82